Quantcast

Latest Type 1 hypersensitivity Stories

2014-08-25 08:24:15

Video Will Aim to Address Gaps in Knowledge About Life-Threatening (Severe) Allergies PITTSBURGH, Aug. 25, 2014 /PRNewswire/ -- Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), and pro football player and EpiPen(®) (epinephrine) Auto-Injector spokesperson Adrian Peterson today announced the three winners of the Ready2Go(TM) MVP Draft, a nationwide search to find kids who have potentially life-threatening (severe) allergies and are prepared...

2014-07-24 16:26:32

OTTAWA, July 24, 2014 The Canadian Society of Allergy and Clinical Immunology (CSACI) would like to comment on the death of Mrs. Lucie Roussel, Mayor of La Prairie, on Sunday. As previously reported, Mrs. Roussel stepped on a wasp nest and was stung multiple times. Unfortunately, the autopsy report is not yet available. It is thought that Mrs. Roussel died from a toxic reaction to the stings which usually requires at least 50 stings, or anaphylaxis which can occur after one sting....

2014-07-10 10:20:50

University of Rochester Medical Center URMC-led study offers hope for atopic dermatitis sufferers An investigational medication shows promise in treating the most common skin disorder, often referred to as eczema or atopic dermatitis, according to a study published July 9 in the New England Journal of Medicine. The findings could eventually bring significant relief for many who suffer intense itching and other troubling features of atopic dermatitis, according to the study's lead...

2014-07-09 16:28:51

Results from Earlier Clinical Trials Published Today in the New England Journal of Medicine TARRYTOWN, N.Y. and PARIS, July 9, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema. All doses of dupilumab met the primary endpoint...

2014-07-09 08:28:37

EpiCeram(R) Controlled Release Skin Barrier Emulsion now offers dosing flexibility with 2 sizes SOUTH PLAINFIELD, N.J., July 9, 2014 /PRNewswire/ -- PuraCap(TM) Pharmaceutical today announced the newest addition to the EpiCeram(R) product line, the EpiCeram(R) 225g Airless Pump. The unique airless pump gives patients more EpiCeram(R) to treat any size area of atopic dermatitis. The special dispensing system allows for more control, delivering EpiCeram(R) consistently and precisely...

2014-07-08 23:15:50

Dignity Sciences Limited finds that a DGLA topical cream (DS107E) has an overall dose response improvement for Atopic Dermatitis in a Phase II clinical trial. Dublin, Ireland (PRWEB) July 08, 2014 Dignity Sciences Limited, a privately held biopharmaceutical company, today announced positive Phase II results for DS107E (DGLA cream), as a topical treatment for atopic dermatitis. This study was a randomized, placebo-controlled, double-blind, multi-centre Phase II study to investigate the...

2014-06-19 23:07:57

A new and highly effective allergy medication is expected to hit the drug market in the near future. The medication is currently under development by doctor and medical researcher in Stavropol Albert Bolatchiev in the Russian federation Stavropol, Russia (PRWEB) June 19, 2014 A new and highly effective allergy medication is expected to hit the drug market in the near future. The medication is currently under development by doctor and medical researcher in Stavropol Albert Bolatchiev in...

2014-06-17 12:30:09

Partnership Represents LETI's Inaugural Launch in North America CHATHAM, N.J., June 17, 2014 /PRNewswire/ -- DermWORX Professional Skincare and LETI Laboratories announce plans to launch a series of top European dermatological products in the United States. This includes LETI's leading dermatology line for atopic skin, AT4, which DermWORX will market to U.S. healthcare professionals and their patients beginning in Q3, 2014. LETI Laboratories, a strategic founding partner for...

2014-06-02 08:26:04

Peterson Calls on Kids with Potentially Life-threatening (Severe) Allergies to Join His Ready2Go MVP Team PITTSBURGH, June 2, 2014 /PRNewswire/ -- Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), and pro football player Adrian Peterson today launched Ready2Go(TM), a new campaign to educate those affected by severe allergies about what to do if a life-threatening allergic reaction, or anaphylaxis, happens. Ready2Go was inspired in part by a...

2014-05-20 23:18:33

Natural Urticaria & Angioedema Treatment system, created by Gary M. Levin, is a brand new program that delivers to urticaria sufferers natural tips to get rid of their problem quickly. A full Natural Urticaria & Angioedema Treatment system review on the site Vkool.com indicates if this program is affordable and safe to use. (PRWEB) May 20, 2014 Natural Urticaria & Angioedema Treatment system is created by Gary M. Levin, who promises to help people get rid of urticaria...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related